HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Cohance Lifesciences submits analyst meet intimation
Sep-17-2026
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cohance Lifesciences has informed that the management of the Company will be attending the below mentioned Conferences on 22nd and 24th September 2026.

The above information is a part of company’s filings submitted to BSE.
  RELATED NEWS >>